Infraorbital Hollows: The Latest in Hyaluronic Acid Filler Treatments
"A novel approach using volumizing fillers demonstrates promising results in treating under-eye hollows."
Infraorbital hollows, commonly known as tear troughs, can create a tired or aged appearance. While various treatments exist, the use of hyaluronic acid fillers has gained traction for its ability to restore volume and rejuvenate the under-eye area. A recent study highlights a promising approach using volumizing hyaluronic acid fillers, offering new hope for individuals seeking a refreshed look.
Traditionally, physicians have been cautious about using high viscous modulus (G') fillers in the tear trough area due to concerns about potential complications. However, a study published in JAMA Facial Plastic Surgery commends Dr. Hall and colleagues for their innovative contribution, demonstrating the safe and effective use of volumizing hyaluronic acid fillers in treating infraorbital hollows.
This article will delve into the details of this novel approach, exploring the benefits, considerations, and potential impact on the field of cosmetic treatments. It aims to provide readers with a comprehensive understanding of how hyaluronic acid fillers can be used to address infraorbital hollows effectively.
Clinical Interest and Re-treatment
A June 20, 2025 article describes hyaluronic acid (HA) as a treatment of choice for attenuating infraorbital grooves and smoothing the eyelid-cheek junction. A 2023 report on HA EYE, a filler described as having high gel strength, says treatment significantly improved moderate and severe infraorbital hollows. It also reports further rejuvenation after re-treatment 12 months after the initial treatment.
The Rise of HA Fillers
Infraorbital HA filler injections were first used in 2005 and have since rapidly gained popularity, according to a 2025 chapter. The chapter attributes this interest to their minimally invasive nature and immediate results. A 2011 overview says HA fillers became the most commonly used injectable filler, citing minimal immunogenicity and relative ease of use. A 2020 history article likewise identifies HA as the most common ingredient in contemporary fillers.
The Science Behind Volumizing Fillers for Tear Troughs
Hyaluronic acid is a naturally occurring substance in the body that helps maintain skin hydration and volume. As we age, the production of hyaluronic acid decreases, leading to volume loss and the formation of wrinkles and hollows. Hyaluronic acid fillers are designed to replenish this lost volume, providing a more youthful and refreshed appearance.
- Low Hydrophilicity: Minimizes the risk of swelling and overcorrection.
- Long Duration: Provides lasting results, reducing the need for frequent touch-ups.
- Supraperiosteal Placement: Ensures a natural-looking result by restoring volume in the deeper layers of the skin.
FDA-Approved Under-Eye Fillers
A pilot evaluation reports that Volbella received FDA approval for injection into the infraorbital region to improve the appearance of under-eye hollows in adults over 21. It also notes that Restylane Eyelight, an HA filler with different rheological properties from Volbella, was more recently FDA-approved for use in this region. The source identifies these products and approvals but does not provide comparative outcome figures in the supplied material.
Evidence and Side-Effect Limitations
A randomized controlled study of VYC-15L notes that follow-up lasted only one month after repeat treatment, limiting continued evaluation of durability. A review of HA filler properties cautions that comparing rheologic studies using different methods is challenging and requires care. A safety review reports that adverse-event patterns vary by injection instrument: needles are associated with greater ecchymosis risk, while cannulas are associated with greater edema risk. Another article describes short- and long-term side effects as very common, citing the thin skin and complex anatomy of the infraorbital area.
Satisfaction, Technique, and Product Selection
A systematic review and meta-analysis reports a pooled overall satisfaction rate of 91.0% for HA injection in tear-trough deformity, with a 95% confidence interval of 84.9% to 95.7%. A separate study reports filler amounts of 0.1 to 0.3 mL per area (mean 0.267 mL ± 0.128 mL) and a mean total of 0.45 mL ± 0.14 mL per eyelid. An expert review emphasizes anatomy, injection strategies, and product selection as considerations for safe, natural outcomes. A supplied study poster describes evaluating HA EYE, a high-gel-strength filler, for effectiveness and safety in correcting infraorbital hollows.
The Future of Under-Eye Rejuvenation
The study by Hall et al. opens new possibilities in the treatment of infraorbital hollows. By demonstrating the safe and effective use of volumizing hyaluronic acid fillers, they have challenged traditional approaches and paved the way for more innovative techniques.
Potential for Under-Eye Aesthetic Treatment
The supplied article describes hyaluronic acid fillers as an innovative, potential solution for people seeking aesthetic improvement in the under-eye area. It characterizes the treatment as changing cosmetic procedures. The snippet does not name a specific future technology, timeline, or projected outcome, so the outlook remains broad.
While the results are promising, it's essential to acknowledge the limitations of the study. The FACE-Q metric, used to assess patient satisfaction, may not fully capture the nuances of aesthetic outcomes. Further research is needed to explore the long-term effects and optimal use of volumizing fillers in the tear trough area.
Overall, this study marks a significant step forward in the field of cosmetic treatments, offering a potential solution for individuals seeking to rejuvenate their under-eye area. As with any cosmetic procedure, it's crucial to consult with a qualified and experienced practitioner to determine the best course of treatment.